Cognizant 2
Cognizant 2
Cognizant 2
Cognizant had a period of fast growth during the 2000s, becoming a Fortune 500
company in 2011.
The company has been involved in a number of controversies in India, the United
Kingdom, and the United States.
Contents
1 History
2 Acquisitions
3 Services
4 Business model
5 Operations
5.1 Regions
5.2 Business units
6 Corporate affairs
6.1 Management
6.2 Finance
6.3 Corporate social responsibility
6.4 Awards
7 Controversies
7.1 India
7.1.1 Bribery
7.1.2 Companies Act violations
7.1.3 Discrimination
7.1.4 Layoffs
7.1.5 Tax evasion
7.2 Ireland
7.2.1 Working conditions
7.3 United States
7.3.1 Corruption
7.3.2 Crawford & Company lawsuit
7.3.3 H-1B visa violations
7.3.4 Working conditions and mental health issues
8 See also
9 References
10 External links
History
Cognizant began as Dun & Bradstreet Satyam Software (DBSS), [6][7] established as
Dun & Bradstreet's in-house technology unit focused on implementing large-scale IT
projects for Dun & Bradstreet businesses. In 1996, the company started pursuing
customers beyond Dun & Bradstreet.[8]
In 1996, Dun & Bradstreet spun off several of its subsidiaries including Erisco,
IMS International, Nielsen Media Research, Pilot Software, Strategic Technologies
and DBSS, to form a new company called Cognizant Corporation. Three months later,
in 1997, DBSS renamed itself to Cognizant Technology Solutions. In July 1997, Dun &
Bradstreet bought Satyam's 24% stake in DBSS for $3.4 million.[9][10] Headquarters
were moved to the United States, and in March 1998, Kumar Mahadeva was named CEO.
[11] Operating as a division of the Cognizant Corporation, the company focused on
Y2K-related projects and web development.[12]
In 1998, the parent company, Cognizant Corporation, split into two companies: IMS
Health and Nielsen Media Research.[13] After this restructuring, Cognizant
Technology Solutions became a public subsidiary of IMS Health. In June 1998, IMS
Health partially spun off the company, conducting an initial public offering of the
Cognizant stock. The company raised $34 million, less than what the IMS Health
underwriters had hoped. They earmarked the money for debt payments and upgrading
company offices.[12]
In April 2018, Cognizant and a consortium of Indian life insurers announced their
development of a blockchain solution aimed at increasing efficiency through
facilitating cross-company data sharing. The platform which is built on Corda, a
DLT platform developed by R3 was claimed to reduce dependency on third-party data
intermediaries and aggregators for obtaining consumer profiles and policy details
such as KYC due diligence, financial and medical underwriting, risk assessment,
fraud detection and regulatory compliance.[22]
Acquisitions